Photo of neonatal foot sensor
Neonatal Trials Group (NTG)

Welcome

The Neonatal Trials Group (NTG) conducts randomized controlled trials on the aspects of neonatal care in babies. 

Originally part of the Clinical Trials Methodology Group, NTG was established as a separate entity in 2006 when it joined the Thrombosis and Hemostasis Program and subsequently became part of TAARI with the move to the new research facility at the David Braley Research Institute. 

NTG’s academic home is in the department of Clinical Epidemiology and Biostatistics in the Faculty of Health Sciences.

Typically, NTG studies assess the efficacy and safety of common, but insufficiently evaluated, neonatal therapies in very small babies born prematurely who spend their first few months in a neonatal intensive care unit (NICU).

The group strives to determine the relative merits of competing care strategies both in terms of

medical outcome in the short-term (to initial discharge from the NICU) but, more importantly, in longer term mental and physical outcome. 

By the standards of the pediatric research community, the trials conducted by NTG are large, with sample sizes of up to 2000 babies. All NTG trials are multi-centered in that eligible babies are recruited from participating Canadian and international NICUs. 

Prof. Robin Roberts

Biostatistician

Prof. Robin Roberts

Dr. Barbara Schmidt

Pediatrician/Neonatal Specialist

Dr. Barbara Schmidt

Dr. Haresh Kirpalani

Pediatrician/Neonatal Specialist

Dr. Haresh Kirpalani

Lorrie Costantini

Research Manager

Lorrie Costantini

Judy D’ilario

Research Nurse/Consultant

Judy D’ilario

Wendy Yacura

Research Assistant

Wendy Yacura

Harvey Nelson

IT/Database Consultant

Harvey Nelson
Website by Electra